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Background: Metabolic syndrome is a cluster of cardiovascular risk factors that greatly increase the risk of
developing cardiovascular disease and type 2 diabetes. Regular exercise improves the risk profile, but most people
do not successfully change their exercise habits to beneficially reduce risk. Tailored exercise prescribed by a family
physician has shown promise as a means to increase fitness and reduce cardiometabolic risk, but optimal
implementation practices remain unknown. Mobile health technologies have proved to be a beneficial tool to
achieve blood pressure and blood glucose control in patients with diabetes. These technologies may address the
limited access to health interventions in rural and remote regions. However, the potential as a tool to support
exercise-based prevention activities is not well understood. This study was undertaken to investigate the effects of a
tailored exercise prescription alone or supported by mobile health technologies to improve metabolic syndrome
and related cardiometabolic risk factors in rural community-dwelling adults at risk for cardiovascular disease and
type 2 diabetes.
Methods/Design: Adults (n = 149) with at least two metabolic syndrome risk factors were recruited from rural
communities and randomized to either: 1) an intervention group receiving an exercise prescription and devices for
monitoring of risk factors with a smartphone data portal equipped with a mobile health application; or 2) an active
control group receiving only an exercise prescription. All participants reported to the research centre at baseline,
and at 12-, 24- and 52-week follow-up visits for measurement of anthropometrics and blood pressure and for a
blood draw to test blood-borne markers of cardiometabolic health. Vascular and autonomic function were
examined. Fitness was assessed and exercise prescribed according to the Step Test and Exercise Prescription protocol.
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Discussion: This study tested the effects of a prescriptive exercise intervention alone, versus one supported by mobile
health technology on cardiometabolic risk factors. The intervention was designed to be translated into clinical or
community-based programming. Results will contribute to the current literature by investigating the
utility of mobile health technology support for exercise prescription interventions to improve cardiometabolic risk status
and maintain improvements over time; particularly in rural communities.
Trial registration: Clinical trials registration: NCT01944124
Keywords: Mobile health, Metabolic syndrome, Exercise prescription, Exercise intervention, Disease prevention, Rural
healthBackground
Cardiovascular disease is the leading cause of death
worldwide accounting for 48% of mortality and 10% of
global disease burden [1]. Cardiovascular complications
are common in patients with type 2 diabetes mellitus,
with heart disease responsible for 68% and stroke re-
sponsible for 16% of mortality in this patient population
in the United States [2]. Metabolic syndrome is a defined
set of risk factors including elevated blood pressure, dys-
glycemia, dyslipidemia and abdominal obesity, which in-
creases the risk of developing cardiovascular diseases
and type 2 diabetes mellitus [3,4]. Metabolic syndrome
risk factors often present concurrently with other global
cardiometabolic risk factors [4], ranging from standard
clinical variables, such as low density lipoprotein and
total cholesterol, high sensitivity C-reactive protein and
body mass index to novel physiologic factors requiring
specialized testing, such as vascular and autonomic func-
tion. While certain risk factors have been identified, it
remains unclear which variables may be clinically im-
portant as early risk markers for cardiovascular compli-
cations. Early identification and management of these
risk factors may be an important strategy for preventing
cardiovascular diseases and type 2 diabetes mellitus.
Metabolic syndrome is highly treatable and lifestyle
changes, including increased physical activity and regular
exercise are recommended as first line treatment [4].
Longitudinal studies have shown that adoption of aer-
obic exercise training in healthy and sedentary middle-
aged adults with metabolic syndrome improved the car-
diometabolic risk profile and reduced the prevalence of
metabolic syndrome [5-8]. Improved lifestyle behaviours
in patients with metabolic syndrome are important to
prevent the progression to chronic diseases, such as type
2 diabetes mellitus. The Diabetes Prevention Program
tested an intensive lifestyle intervention with the goal of
seven percent weight loss through a low-calorie, low-fat
diet along with participation in a minimum of 150
minutes of moderate-to-vigorous physical activity per
week [9]. This lifestyle intervention was more effective
in preventing type 2 diabetes mellitus than pharmaco-
logical therapy with metformin or placebo plus standardlifestyle recommendations in overweight adults with
impaired glucose tolerance [9]. At an average follow-up
of 2.8 y, incident diabetes was 31% less in the metfor-
min group and 58% less in the intensive lifestyle inter-
vention group compared to the placebo group [9].
These studies highlight the importance of physical ac-
tivity and exercise to manage risk and prevent progres-
sion to chronic disease.
Despite the known benefits of exercise, accelerometer
data showed that 85% of Canadians [10] and 90% of
Americans [11] do not meet physical activity guidelines.
Exercise prescription in primary care may be an effective
strategy to increase physical activity [12-14]. A system-
atic review concluded that exercise prescription inter-
ventions were effective at increasing physical activity,
especially when they included a written prescription,
considered behaviour change strategies and provided
training and materials for physicians [14]. Despite
known benefits, implementation in primary care remains
low due to a gap in our understanding of how to best
target and deliver individualized exercise prescriptions
to patients at risk in the community.
In recent years, mobile technologies have been used as
a medium for implementing health monitoring interven-
tions. Mobile health has been used as a tool to support
patient management of chronic diseases including type 2
diabetes mellitus [15] and hypertension [16-18], but little
attention has been paid to leveraging mobile health tech-
nologies for risk management for disease prevention. To
date, one pilot study examined the effects of a cardiovas-
cular disease prevention intervention using an electronic
health intervention with a mobile health component to
manage metabolic syndrome risk factors [19]. The work-
place electronic health program consisted of a four-week
education module (60 minutes per session) plus access
to telephone counseling, short message service messages
and/or email messages for six months. Body fat, blood
pressure and pedometer steps were regularly monitored.
Following six months, waist circumference, systolic and
diastolic blood pressure and triglycerides were reduced,
with no changes in fasting plasma glucose or high dens-
ity lipoprotein cholesterol [19]. This six-month eHealth
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was limited to a population of workers whose employers
accepted the Healthy Workplace Program. Additionally,
fasting plasma glucose was not monitored despite evi-
dence from interventions in patients with type 2 diabetes
mellitus supporting home-monitoring as an effective
tool for improving fasting plasma glucose [15].
Access to healthcare is often reduced in rural compared
to urban communities. For example, Huron County in
rural southwestern Ontario has a 27.5% physician vacancy
rate (number of positions available for general practi-
tioners) compared to 0% vacancy rate in nearby urban
centres [20]. Innovative technologies including mobile
health monitoring have the potential to increase access to
healthcare. Our group completed a pilot study testing the
feasibility and utility of deploying a mobile health technol-
ogy kit for self-management of metabolic syndrome risk
factors and physical activity in a rural population [21,22].
Twenty-four participants aged 30-72 years monitored
their blood pressure three times per week and blood glu-
cose two times per day with Bluetooth™ enabled devices
paired with a smartphone. Additionally, pedometer steps
were manually inputted daily and body weight was input-
ted weekly [21,22]. A health monitoring system including
an application on the smartphone and a secure online
database was used to transmit and store data [21]. Alarms
were triggered when measurements were outside of pre-
determined limits. Following the eight-week intervention,
waist circumference, diastolic blood pressure and total
cholesterol were reduced, physical activity and fitness were
increased [22], and autonomic function was improved
[23]. Furthermore, participants reported that the technol-
ogy assisted in adopting new practices to improve well-
being and did not take too much time or interfere with
activities of daily living [21]. This study, however, could
not conclude whether the mobile health protocol had
added benefit to the exercise prescription.
Therefore, the purpose of this trial was to investigate the
effects of a mobile health supported exercise prescription,
compared to exercise prescription alone on metabolic syn-
drome and other global cardiometabolic risk factors in in-
dividuals at risk for cardiovascular disease and type 2
diabetes. It was hypothesized that the primary outcome,
systolic blood pressure, and secondary outcomes would be
improved in both groups, but to a greater extent in the
mobile health intervention group at 12 weeks and that
these changes would be better maintained at 24 and
52 weeks in the intervention group with mobile health
support compared with the active control group.
Methods/Design
Study design
This study was a randomized controlled trial with
two intervention arms: 1) the intervention group, whichreceived a tailored exercise prescription and a mobile
health technology kit; and 2) the active control group,
which received only a tailored exercise prescription.
Adults aged 18-70 years were screened for inclusion.
Participants (n = 149) presenting with at least two meta-
bolic syndrome risk factors reported to the clinic (Gate-
way Rural Health Research Centre, Seaforth, Ontario,
Canada) at baseline (V0) and for 12- (V1), 24- (V2) and
52-week (V3) follow-up visits.
Recruitment and screening process
This study was approved by the University of Western
Ontario Research Ethics Board (Protocol #15828).
Community-dwelling adults aged 18-70 years were re-
cruited via newspaper or radio advertisement, flyers, re-
ferral from healthcare professional and word of mouth.
Interested candidates contacted the study coordinator
for telephone screening. Participants were eligible if they
had two or more metabolic syndrome risk factors ac-
cording to National Cholesterol Education Program
Adult Treatment Panel III criteria: waist circumference
≥ 88 cm (women) or ≥ 102 cm (men); systolic blood
pressure ≥ 135 mmHg and/or diastolic blood pressure
≥ 85 mmHg; fasting plasma glucose ≥ 6.1 mmol/L; tri-
glycerides ≥ 1.7 mmol/L; and high density lipoprotein
cholesterol ≤ 1.29 mmol/L (women) or ≤ 1.02 mmol/L
(men) [24]. Exclusion criteria were: systolic blood pres-
sure > 180 mmHg and/or diastolic blood pressure
> 110 mmHg; type 1 diabetes; history of myocardial in-
farction, angioplasty, coronary artery bypass or cerebro-
vascular ischemia/stroke; symptomatic congestive heart
failure; atrial flutter; unstable angina; unstable pulmonary
disease; use of medications known to affect heart rate; sec-
ond or third degree heart block; history of alcoholism,
drug abuse or other emotional cognitive or psychiatric
problems; pacemaker; unstable metabolic disease and
orthopedic or rheumatologic problems that could impair
the ability to exercise. Participants who passed the initial
screening were booked for a V0 appointment. To facilitate
scheduling of group mobile health technology training ses-
sions, block randomization was used, such that all partici-
pants attending appointments during week one were
allocated to the intervention group and all participants at-
tending appointments during week two were allocated to
the control group and so on.
Final eligibility screening at baseline visit
Participants who qualified for the study reported to
the clinic following an eight hour fast. Participants
were instructed to abstain from caffeinated or alco-
holic beverages for 12 hours and intense physical ac-
tivity for 24 hours prior to their study visits. Voluntary
informed consent was obtained from all participants.
Inclusion and exclusion criteria were verified by a
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syndrome risk factors.
Laboratory procedures for baseline and follow-up visits
Demographics and medical history
During the baseline visit only, participant demographics re-
corded included: date of birth, sex, race and postal code. An
interview was then conducted to determine medical history,
which included documenting information regarding smok-
ing status, alcohol consumption, history of heart/vascular
disease, history of endocrine disease, gynecological history,
lifestyle habits, past illnesses and surgeries, and current
medications. While the full interview was conducted only at
baseline, it was requested that participants contact the study
coordinator should there be any change in any of these
items and at each follow-up visit participants were asked if
there was any change in medication or health status.
Physical examination
At each study visit, anthropometrics were measured.
Body weight was measured with an automated scale and
height was measured with a standard stadiometer in
light clothing with shoes removed. Waist circumference
was measured (to the nearest 0.5 cm) following a normal
exhalation at the mid-point between the twelfth rib and
superior boarder of the iliac crest [25]. Blood pressure
was measured with an automated device (BPTru®,
Coquitlam, Canada) in the supine position following a
five-minute rest period. The average of the last two of
three measures was used to determine resting blood
pressure (to the nearest 1 mmHg). Participants contin-
ued to rest supine for an additional 30 mins after which
research personnel certified in venipuncture drew blood
from the anticubital vein. Blood was sent to a central la-
boratory (GammaDyna Care, London, Ontario) for ana-
lysis of fasting plasma glucose, lipid profile, glycated
hemoglobin, insulin, high sensitivity C-reactive protien,
catecholamines, and estrogen.
Vascular and autonomic testing
Upon completion of the venipuncture procedure, a stan-
dardized snack was consumed. Participants were instru-
mented for collection of continuous R-R intervals with a
lead II electrocardiogram (Colin Pilot 9200, Colin Med-
ical Instruments, San Antonio, Texas) and respiratory
rate by belt transducer (Pneumotrace II, ADInstruments,
Colorado Springs, Colorado) secured around the thorax.
Data were collected during ten minutes of supine rest,
with external stimuli such as light and noise controlled
to ensure signal stability. All measures were sampled at
1000 Hz, input into a data acquisition board (PowerLab
ML795, ADInstruments) for analog-to-digital signal con-
version with LabChart7Pro software (ADInstruments)
and stored for offline analysis.The left carotid and brachial arteries were imaged longi-
tudinally just proximal to the carotid sinus and anticubital
fossa, respectively, using B mode ultrasound (VingMed
System 5, GE Ultrasound A/S, Horton, Norway). The
average of three measures of each systolic and diastolic
diameter and intima media thickness were recorded for
each site. A sphygmomanometer blood pressure cuff was
then secured on the left forearm just distal to the elbow
for assessment of flow mediated dilation [26]. The brachial
artery was imaged as described above. The cuff was in-
flated to 200 mmHg for five minutes and then deflated to
induce reactive hyperemia. Beat-by-beat flow and continu-
ous brachial arterial diameter were recorded with Doppler
ultrasound for five minutes following the release of the
pressure cuff.
Fitness assessment and exercise prescription
The Step Test and Exercise Prescription (STEP™) protocol
was used for fitness assessment and exercise prescription.
This tool is endorsed by the College of Family Physicians
of Canada as part of accredited Continuing Health Educa-
tion curriculum for improving physical activity education
among family physicians. It has been validated in adults
aged 18-65 years, (Unpublished observations) and 65-85
years [27]. In adults aged 18-65 years, the fitness assess-
ment was shown to overestimate fitness by 7 ml/kg/min
[Unpublished observations]. However, since STEP™ results
(i.e. aerobic fitness) are used as a motivational tool, its use
has been recommended for counselling and prescription
purposes, but not as a primary outcome measure [Unpub-
lished observations]. STEP™ has proved useful as a tool in
primary care to increase physical activity and improve
metabolic syndrome and global cardiometabolic risk
factors [28].
The STEP™ test was conducted by a research assistant
with training in kinesiology. Resting heart rate was mea-
sured by palpation of the radial artery for 10 seconds.
Participants were instructed to step up and down a set
of two steps (each with a 20 cm rise) twenty times at a
pace considered normal for climbing stairs (Figure 1).
Upon completion of the test, post-exercise heart rate
was palpated from the radial artery for a 10-second
count. Time to complete the test (in seconds) and post-
exercise heart rate (in beats per minute; bpm) were en-
tered into an equation to estimate fitness (maximal oxy-
gen uptake) [28]. Fitness was classified as poor, fair, good
or excellent based on age, sex and maximal oxygen up-
take (Additional file 1).
The same research assistant who conducted the STEP™
test counselled the participant and prepared an individu-
alized exercise prescription based on fitness and partici-
pant preferences. Participants worked with the research
assistant to identify three personal fitness goals. Add-
itionally, barriers to exercise or lifestyle changes were
Figure 1 Step Test and Exercise Prescription (STEP™) protocol.
Stuckey et al. BMC Public Health 2013, 13:1051 Page 5 of 10
http://www.biomedcentral.com/1471-2458/13/1051identified and strategies to overcome these barriers were
developed. The final exercise prescription was based on
American College of Sports Medicine guidelines [29]
and included the frequency, intensity, type and duration
of exercise. Frequency was ideally set at (or increased to)
most days of the week. Training heart rate was calcu-
lated as a percentage of the age predicted maximum
heart rate (220-age) and was based on fitness classifica-
tion from the STEP™ fitness assessment with 70, 75, 80
and 85% of predicted maximum heart rate prescribed
for participants with poor, fair, good and excellent fit-
ness, respectively. The type of exercise most commonly
prescribed was walking, but other aerobic activities were
also chosen including, but not limited to, aerobic exer-
cise classes, swimming, cycling and team sports. Resist-
ance exercises were also prescribed one to three days
per week, depending on fitness, and consisted of exer-
cises such as squats, calf raises and push ups. When par-
ticipants had equipment available to them for resistanceexercise, programs were designed specific to their needs.
All participants were encouraged to accumulate a mini-
mum of 150 minutes per week of moderate-to-vigorous
intensity physical activity according to global guidelines
[30]. Exercise bouts could be a minimum of 10 minutes
with the goal of increasing time to 30 minutes per ses-
sion or more. Since participants in the intervention
group received a pedometer, step goals were also in-
cluded in their prescription [31].
Participants in the active control group were given a
journal to log their activity daily including exercise heart
rate. The intervention group logged their activity with
their mobile health monitoring application (see below).
Behavioural and health status questionnaires
Participants completed the Short Form-36 questionnaire
[32]. Raw scores were transformed using the guidelines
developed by Medical Outcomes Trust. Eight dimensions
of quality of life were examined: physical functioning; role-
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health; social functioning; and general health. Raw scores
were converted to a score out of 100 for each dimension,
with 0 and 100 representing an extremely poor and ex-
tremely good quality of life, respectively. The SF-36 has
proved to be valid and reliable [33,34]. Dietary habits, ex-
ercise, blood glucose testing, foot care and smoking habits
were recorded using the Summary of Diabetes Self-Care
Activities survey, which is a brief, reliable and valid meas-
ure of these lifestyle behaviours [35].
The Decisional Balance scale was used to assess percep-
tions of pros and cons to participating in exercise [36] and
the Exercise Self-efficacy scale was used to assess confi-
dence in participating in an exercise program [37].
A survey assessing current technology use, comfort with
and burden of technology was administered at each visit
to the intervention group. The active control group also
completed a survey at V3. This survey was included solely
to receive feedback regarding the technology, which would
be used to modify the protocol for future studies.
Mobile health technology
In addition to the exercise prescription, the intervention
group also received a mobile health technology kit for
self-monitoring of biometrics and physical activity. We
previously tested the feasibility of delivering this interven-
tion to this population and showed that the technology
was accepted and motivational to participants in the pilot
study [21]. The kit included a smartphone (Blackberry®
Curve 8300 or 8530) equipped with Healthanywhere
health monitoring application (Biosign Technologies
Inc., Markham, Ontario, Canada), a Bluetooth™ enabled
blood pressure monitor (A & D Medical, UA-767PBT,
San Jose, California, USA), a glucometer (Lifescan
One Touch Ultra2™, Milpitas, California, USA) with
Bluetooth™ adapter (Polymap Wireless, PWR-08-03,
Tucson, Arizona, USA) and a pedometer (Omron, HJ-
150, Kyoto, Japan). All participants were required to at-
tend a group training session (approximately two-hour
duration) following V0. Those who could not attend
group training sessions were given an individual train-
ing session at the end of their baseline visit. During the
training session, participants were instructed on proper
use of devices and techniques to ensure proper mea-
surements. Participants were given the opportunity to
practice taking measurements, to ask any questions re-
lated to the mobile health protocol and were provided
with a telephone number and email address of study
personnel for troubleshooting.
Throughout the intervention period, home blood pres-
sure and fasting plasma glucose were to be submitted
thrice weekly upon waking. Blood pressure was to be
taken in the seated position with feet flat on the floor,
back supported and arm supported at heart height.Blood pressure was measured once following five mi-
nutes of seated rest. Fasting plasma glucose was mea-
sured prior to consumption of food or drink. The
pedometer was to be attached to the waistband at the
front of the hip daily upon waking and removed just
before bed (or during activities that could damage
the pedometer, such as swimming and contact sports).
Pedometer steps were input nightly. Home body weight
was measured monthly with consistent timing and
equipment. All submitted measures were date and time
stamped and transmitted in real time to a secure database
that was monitored by research personnel. Thresholds
were set for systolic blood pressure (60-220 mmHg), dia-
stolic blood pressure (40-110 mmHg) and fasting plasma
glucose (3.0-15.0 mmol/L). Submitted readings that were
outside these limits triggered an alarm that was sent to the
study physician’s smartphone for immediate follow-up.
Trends for consistently increasing measures were moni-
tored by research assistants and brought to the study phy-
sician’s attention as necessary for follow-up.
Exercise was logged with the Healthanywhere activity
tracking module. An individualized list of activities and
target heart rate from the participant’s exercise prescrip-
tion was compiled, and the participant was to select the
completed activity and heart rate achieved following
each planned exercise session.
Participants received a heart rate monitor (Suunto
Memory Belt, Vantaa, Finland), which was secured around
the chest on three occasions during the week following
each visit. On the least active day of the week, participants
were to wear the monitor for a 24-hour period and on two
separate occasions they were to perform an orthostatic
challenge with five minutes each of supine rest, seated
rest and quiet standing. Heart rate monitors were
returned to the clinic and data were downloaded to a
personal computer with Suunto Training Manager soft-
ware (Version 2.3.0).
Details of security for data transfer and database stor-
age has been reported elsewhere [21]. Briefly, real-time
data were encrypted and transmitted from the smart-
phone to the server and database by secure internet
protocol. Biometric data were deidentified for transmis-
sion and linked to participant data once on the protected
server. Database access was limited to authorized re-
searchers. Healthanywhere accounts were controlled and
protected remotely so that in the case of device loss, the
account could be deactivated to prevent unauthorized
access to participant health information.
Data processing
Mobile health
Deidentified health data will be downloaded from the
Healthanywhere database for offline analysis. Compli-
ance to the self-monitoring protocol will be calculated
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overall and for each device. The average of monthly mea-
surements will be calculated and used to examine change
in mobile health biometric and physical activity measures
over time. Data from mobile health exercise logs will be
processed the same as paper logs, described below.
Exercise log data
Entries from exercise logs will be input to a personal
computer and coded according to exercise type. Exercise
data will be used for descriptive purposes only and exer-
cise characteristics such as frequency, duration and in-
tensity were documented. Compliance to the exercise
prescription will be examined by calculating the percent-
age of exercise sessions completed.
Heart rate variability processing
Data files from electrocardiogram collection of R-R
interval in the clinic in all participants and home moni-
toring of R-R interval for 24 hours and during an ortho-
static challenge will be converted to text files for analysis
with heart rate variability software (Hearts v7, Heart Sig-
nal Co., Oulu, Finland). Editing of the R-R interval time
series is to be performed by a single investigator. All
electrocardiogram signals will be manually scanned for
ectopic or non-sinus beats, which will be deleted from
the time series. Ninety percent of data are needed for in-
clusion of short-term heart rate variability recordings
and 80% of data are needed for inclusion of long-term
24-hour recordings. Time domain heart rate variability
analyses include heart rate, standard deviation of
normal-to-normal intervals the root square mean of suc-
cessive differences. The heart rate variability spectrum
will be computed with the non-parametric fast Fourier
transform method. Ultra low (0.0-0.003 Hz) and very
low frequency powers (0.003-0.04) will be examined for
24-hour data and low (0.04-0.15 Hz) and high frequency
powers (0.15-0.4 Hz) and the low-to-high frequency
power ratio will be examined for both 24-hour and
short-term data. A Poincaré plot will be formed by plot-
ting each R-R interval against the following one to create
a scatter plot. The standard deviation of the width and
length will be calculated. The detrended fluctuation ana-
lysis method will be used to examine fractal characteris-
tics of heart rate fluctuations. The root-mean square
fluctuations of integrated and detrended data will be
measured in observation windows and then plotted
against the size of the window on a log-log scale. α1 will
be calculated from the slope of the line (from 4-11
beats). Approximate entropy quantifies the regularity
of time series data by calculating the likelihood that
runs of patterns that are close will remain close on the
next incremental comparison. A greater value represents
greater unpredictability in a system. Approximate entropywill be calculated from 500 beats and will be computed
with length, m = 2 and tolerance, r = 20%.
Vascular data processing
Systolic and diastolic radiuses along with pulse pressure
will be entered into equations to calculate arterial compli-
ance and distensibility [38]. Flow mediated dilation will be
calculated as the maximal percentage increase in vessel
diameter above baseline and percent change, absolute
change and baseline diameter will be reported [39].
Statistical analysis
Outcome measures
Clinic systolic blood pressure was chosen as the primary
outcome measure.
Secondary outcomes included other metabolic syn-
drome, clinical and novel cardiometabolic risk factors.
Scores from behavioural and health status questionnaires
were also included in secondary outcomes.
Tertiary outcomes were mobile health variables in-
cluding biometrics, activity and compliance to the moni-
toring protocol.
Sample size calculation
The sample size was based on differences in mean change
between the intervention and active control groups in sys-
tolic blood pressure (primary outcome measure) at 12-
weeks. The sample size calculation assumed 80% power
and two-sided significance level of 0.05. We estimated that
the smallest difference between groups in mean change
that would be expected was 6 mmHg and we assumed a
common standard deviation of 12 mmHg. Therefore, it
was determined that 63 participants would be required per
group. By assuming a 15% drop-out rate, this would in-
crease our required sample size to 73 participants per
group. Since we are using an Analysis of Covariance
(ANCOVA) to perform data analysis (primary analysis), this
sample size estimation may be considered conservative.
Data will be analysed following the Intent-to-Treat ap-
proach. Analyses will include all safety evaluable patients
who have both baseline and valid post-baseline data. In
instances where a participant may not have completed
the final visit of the protocol but was subjected to the
above procedures before study termination, a last obser-
vation carried forward approach will be used for analysis.
Baseline data will not be carried forward.
For all continuous outcome variables, distributions will
be examined to assess normality and presence of out-
liers; transformations will be undertaken as appropriate.
For categorical outcome variables, frequency tables will
be examined to ensure there are no out-of-range values.
Descriptive statistics will be computed for baseline
demographic characteristics and for all outcome measures,
at each time point. Specifically, means and standard
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frequency counts and percentages will be calculated for
categorical variables.
12-week analyses
For all continuous outcomes, ANCOVA will be used to
examine differences in mean change between and within
groups, while adjusting for baseline levels of the out-
come of interest. For categorical outcomes, binary vari-
ables will be derived and we will use logistic regression
to model the odds of improvement in either the inter-
vention or active control group, while adjusting for base-
line levels of the outcome of interest.
52-week analyses
The 12-week analyses will be extended to include data
collected at all time-points. Linear mixed models will
be used for continuous outcomes. Within these models,
the group variable will indicate differences between
groups at baseline, the time variable will indicate
change over time in the reference (i.e., active control)
group, and the group × time variable will indicate
whether change over time differs between groups. Con-
trast statements will be used to determine change over
time in the intervention group.
A similar approach will be followed for categorical var-
iables; however, generalized linear (logistic) mixed
models will be used instead. Interpretation of study re-
sults will be primarily based on estimation and associ-
ated 95% confidence intervals [40]. Analyses will be
performed using R 3.0.1 [41].
Discussion
This study investigated the effects of an exercise pre-
scription supported by mobile health technology com-
pared to an exercise prescription alone to improve
metabolic syndrome and global cardiometabolic risk fac-
tors in rural community-dwelling adults. It was hypothe-
sized that the primary outcome systolic blood pressure
would be reduced to a greater extent in the mobile
health-supported intervention group at 12-weeks and
that this improvement would be better maintained in
the intervention group for the remainder of the year-
long trial. Similar improvements in secondary clinical
outcomes as well as more novel cardiometabolic risk pa-
rameters including autonomic and vascular function
were expected.
Interventions aimed at preventing chronic disease are
important in rural communities with increased cardio-
metabolic risk and reduced access to healthcare. This
study included adults from a rural community with
greater prevalence of obesity, diabetes and hypertension
than the provincial average [42] and reduced access to
healthcare compared to urban communities [20]. Thus,it was considered an ideal setting for an intervention le-
veraging novel mobile health technologies to promote
increased physical activity to reduce cardiovascular risk.
Exercise is known to have positive health benefits. The
effects of exercise on individual metabolic syndrome risk
factors have been reviewed extensively [4,43,44]. One
meta-analysis examined the effects of exercise on meta-
bolic syndrome risk factors in studies on populations
with metabolic syndrome [6]. Of the studies included in
the meta-analysis, training interventions were 8 to
52 weeks duration, frequency of two to five sessions per
week for 40-60 minutes per session at moderate to high
intensity, with the exception of one study which exam-
ined low intensity exercise. Endurance exercise training
reduced waist circumference, systolic blood pressure and
diastolic blood pressure and increased high density lipo-
protein cholesterol, with no changes in fasting plasma
glucose or triglcerides [6]. However, baseline fasting
plasma glucose was within the normal range. Improve-
ments would be expected if fasting plasma glucose was
outside the normal range, as exercise improved HbA1c
in patients with type 2 diabetes mellitus [45]. Addition-
ally, lifestyle interventions have been shown to improve
autonomic [23,46-48] and vascular function [49,50]. Im-
portantly, improvements in heart rate variability with
lifestyle interventions were associated with lower risk of
incident diabetes, independent of weight loss and phys-
ical activity [51].
Physician prescribed exercise has proved to effectively
increase physical activity [13,14] and use of the STEP™
tool for fitness assessment and exercise prescription has
been observed to improve the cardiometabolic risk pro-
file of patients at risk [28]. A recent meta-analysis
showed that STEP™ was the most effective prescription
tool for increasing cardiorespiratory fitness, and it was
suggested that this may be due to the inclusion of a
training heart rate to ensure that the appropriate inten-
sity of exercise was achieved [13]. Importantly, increased
cardiorespiratory fitness reduced cardiovascular mortal-
ity in men [52]. However, with the current healthcare
system, allied healthcare professionals may be more ap-
propriate personnel to deliver STEP™. Hence, this trial
will utilize a kinesiology-trained research assistant to as-
sess fitness and prescribe exercise.
Intensive lifestyle intervention programs reduced the
risk of developing type 2 diabetes mellitus in patients
with prediabetes and improvements were maintained
over a long-term follow-up; however, there was a strong
relationship between reduced disease progression and
continuance of lifestyle intervention behaviours [53].
This finding highlights the importance of post-program
support for long-term maintenance. Implementation ac-
tivities are important to translate research protocols into
useable programs and a knowledge translation program
Stuckey et al. BMC Public Health 2013, 13:1051 Page 9 of 10
http://www.biomedcentral.com/1471-2458/13/1051including the construction of a national network of part-
ners with interest in rural health and chronic disease
management has been planned. A range of knowledge
translation strategies will be utilized, including community
consultations, physician and allied health provider presen-
tations, scientific presentations and publications, town-hall
meetings and gray literature publications among our end-
users to ensure exposure and uptake among stakeholders.
This study was limited in that participants volunteered
to enroll in the study. Thus, the study population con-
sisted of highly motivated individuals who were inter-
ested in lifestyle improvements. Therefore, the findings
may not be generalizable to a general clinic population,
as many at-risk patients are not motivated to change
their behaviours. Additionally, participants were limited
to using study-provided smartphones to ensure data se-
curity. Whether differing devices and data providers will
be similar is unknown.
In conclusion, this trial tested an intervention utilizing
exercise prescription and mobile health monitoring tech-
nologies. Learnings from this study will be used to en-
hance the delivery of lifestyle interventions aimed at
improving cardiometabolic risk, with the intention of re-
ducing incident cardiovascular diseases and type 2 dia-
betes mellitus.
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